respiratory
Asthma

In their own words: patients describe the benefits and limits of mAbs for severe asthma

Patients with severe asthma experience significant improvements in quality-of-life and participation in life with add-on monoclonal antibody therapies but there’s still more to be done. Semi-structured interviews with 20 Australian patients revealed four emergent themes – that life is just easier, prednisone – a necessary evil, worry and hope for the future, and holistic care. ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic